Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose in mild iron deficiency anemia before arterial vascular surgery
NL-OMON38492Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Change in exercise tolerance. Started Jan 2014; status: active, not recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NL-OMON38492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38492.